Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H C Neu

Showing results (111-120 of 505) with videos related to

Pageof 51
Sort By:
Journal of Clinical Pharmacology|August 1, 1992
Once-daily oral antimicrobial therapy: is a consensus possible?H C Neu
Texas Heart Institute Journal|January 1, 1990
Use of fluoroquinolone antimicrobial agents by cardiovascular and cardiopulmonary surgeonsH C Neu
Infection Control and Hospital Epidemiology|January 1, 1992
Resistance of Pseudomonas aeruginosa to imipenemH C Neu
Bulletin of the New York Academy of Medicine|September 1, 1984
Infections in intensive care patients: use of new B-lactamsH C Neu
Therapeutic Drug Monitoring|January 1, 1981
A review and summary of the pharmacokinetics of cefoperazone: a new, extended-spectrum beta-lactam antibioticH C Neu
The American Journal of Medicine|May 15, 1984
Current mechanisms of resistance to antimicrobial agents in microorganisms causing infection in the patient at risk for infectionH C Neu
Disease-A-Month : DM|October 1, 1984
Unusual nosocomial infectionsH C Neu
The Journal of Antimicrobial Chemotherapy|January 1, 1982
The efficacy of mezlocillin in the therapy of bacteraemiaH C Neu
The American Journal of Medicine|December 29, 1989
Chemical evolution of the fluoroquinolone antimicrobial agentsH C Neu
Antibiotics and Chemotherapy|January 1, 1992
Microbiology of bacterial meningitis pathogensH C Neu
Pageof 51

Showing results (111-120 of 505) with videos related to

Sort By:
Pageof 51
Journal of Clinical Pharmacology|August 1, 1992
Once-daily oral antimicrobial therapy: is a consensus possible?H C Neu
Texas Heart Institute Journal|January 1, 1990
Use of fluoroquinolone antimicrobial agents by cardiovascular and cardiopulmonary surgeonsH C Neu
Infection Control and Hospital Epidemiology|January 1, 1992
Resistance of Pseudomonas aeruginosa to imipenemH C Neu
Bulletin of the New York Academy of Medicine|September 1, 1984
Infections in intensive care patients: use of new B-lactamsH C Neu
Therapeutic Drug Monitoring|January 1, 1981
A review and summary of the pharmacokinetics of cefoperazone: a new, extended-spectrum beta-lactam antibioticH C Neu
The American Journal of Medicine|May 15, 1984
Current mechanisms of resistance to antimicrobial agents in microorganisms causing infection in the patient at risk for infectionH C Neu
Disease-A-Month : DM|October 1, 1984
Unusual nosocomial infectionsH C Neu
The Journal of Antimicrobial Chemotherapy|January 1, 1982
The efficacy of mezlocillin in the therapy of bacteraemiaH C Neu
The American Journal of Medicine|December 29, 1989
Chemical evolution of the fluoroquinolone antimicrobial agentsH C Neu
Antibiotics and Chemotherapy|January 1, 1992
Microbiology of bacterial meningitis pathogensH C Neu
Pageof 51